DREAM-HF trial results highlight Mesoblast’s potential to differentiate in HF space: GlobalData
Revascor shows potential in reducing cardiovascular mortality and improving outcomes in high-risk heart failure patients, marking…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.